Outcomes of patients with IDH1-mutant relapsed or refractory acute myeloid leukemia receiving ivosidenib who proceeded to hematopoietic stem cell transplant.

Journal Article (Journal Article;Multicenter Study)

Full Text

Duke Authors

Cited Authors

  • DiNardo, CD; Stein, EM; Pigneux, A; Altman, JK; Collins, R; Erba, HP; Watts, JM; Uy, GL; Winkler, T; Wang, H; Choe, S; Liu, H; Wu, B; Kapsalis, SM; Roboz, GJ; de Botton, S

Published Date

  • November 2021

Published In

Volume / Issue

  • 35 / 11

Start / End Page

  • 3278 - 3281

PubMed ID

  • 33772143

Pubmed Central ID

  • PMC8464620

Electronic International Standard Serial Number (EISSN)

  • 1476-5551

Digital Object Identifier (DOI)

  • 10.1038/s41375-021-01229-x

Language

  • eng

Conference Location

  • England